X-150770368-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_031462.4(CD99L2):āc.657G>Cā(p.Gln219His) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000182 in 1,209,335 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_031462.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD99L2 | NM_031462.4 | c.657G>C | p.Gln219His | missense_variant, splice_region_variant | 10/11 | ENST00000370377.8 | NP_113650.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD99L2 | ENST00000370377.8 | c.657G>C | p.Gln219His | missense_variant, splice_region_variant | 10/11 | 1 | NM_031462.4 | ENSP00000359403.3 |
Frequencies
GnomAD3 genomes AF: 0.0000535 AC: 6AN: 112184Hom.: 0 Cov.: 24 AF XY: 0.0000291 AC XY: 1AN XY: 34370
GnomAD3 exomes AF: 0.0000492 AC: 9AN: 183072Hom.: 0 AF XY: 0.0000444 AC XY: 3AN XY: 67548
GnomAD4 exome AF: 0.0000146 AC: 16AN: 1097151Hom.: 0 Cov.: 29 AF XY: 0.00000828 AC XY: 3AN XY: 362519
GnomAD4 genome AF: 0.0000535 AC: 6AN: 112184Hom.: 0 Cov.: 24 AF XY: 0.0000291 AC XY: 1AN XY: 34370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 10, 2024 | The c.687G>C (p.E229D) alteration is located in exon 11 (coding exon 11) of the CD99L2 gene. This alteration results from a G to C substitution at nucleotide position 687, causing the glutamic acid (E) at amino acid position 229 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at